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1 Abstract 1 
Disseminating the practice of minimally invasive mitral surgery (mini-MVS) can be 2 
challenging, despite its original case reports a few decades ago. The penetration of 3 
this technology into clinical practice has been limited to centres of excellence and 4 
mitral surgery in most general cardiothoracic centres remains to be conducted via 5 
sternotomy access as a first line.  The process for the uptake of mini-MVS requires 6 
clearer guidance and standardisation for the processes involved in its 7 
implementation.  8 
 9 
In this statement, a consensus agreement is outlined that describes the benefits of 10 
mini-MVS, including reduced post-operative bleeding, reduced wound infection, 11 
enhanced recovery and patient satisfaction. Technical considerations require specific 12 
attention and can introduced through simulation and/or use in conventional cases. 13 
Either endoballoon or aortic cross clamping are both recommended as well as 14 
femoral or central aortic cannulation, with the use of appropriate adjuncts and 15 
instruments.  16 
 17 
A coordinated team-based approach that encourages ownership of the programme 18 
by the team members is critical. A designated proctor is also recommended. The 19 
organisation of structured training and simulation, as well as planning the initial 20 
cases are important steps to consider.  21 
 22 
The importance of pre-empting complications and dealing with adverse events are 23 
described, including re-exploration, conversion to sternotomy, uni-lateral pulmonary 24 
oedema and phrenic nerve injury. Accounting for both institutional and team 25 
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 4 
considerations can effectively facilitate the introduction of a mini-MVS service. This 1 
involves simulation, team-based training, visits to specialist centres and involvement 2 
of a designated proctor to oversee the initial cases.   3 
 4 
 5 
2 Introduction 6 
In the current era of surgeon-specific outcome publication, cardiac surgery in the 7 
NHS has adopted a culture of evolutionary practice as opposed to revolutionary 8 
progression(1). The process of introducing new technologies and procedures is 9 
multifaceted, underpinned by the demonstration of both patient safety as well as 10 
clinical effectiveness. The innovation of techniques in minimally access mitral 11 
surgery (mini-MVS) has dominated the cardiothoracic community for the last 2 12 
decades. Despite this, the penetration of this technology into clinical practice has 13 
been limited to centres of excellence and mitral surgery in most general 14 
cardiothoracic centres remains to be conducted via sternotomy access as a first line.  15 
When compared to the conventional sternotomy approach, the procedure has 16 
implications for the surgeon, surgical team and post-operative healthcare staff with 17 
regards to surgical equipment, perioperative parameters and bedside adjuncts(2). 18 
These in turn requires a common agreement on the use of appropriate outcome 19 
metrics and benchmarking.  20 
 21 
This consensus report will serve to comprehensively review the evidence for the 22 
practice of mini-MVS and use this to highlight the important considerations when 23 
initiating a new mini-MVS programme in a UK Healthcare Trust.  24 




3 Evidence for minimally invasive mitral surgery  2 
There are currently no adequately powered randomised controlled trial data 3 
comparing minimally invasive and conventional mitral valve surgery. However, Mini-4 
MVS has shown to have benefits demonstrated through specific metrics as 5 
described below.  6 
3.1 Reduced post-operative bleeding 7 
One of the main worries of mini-MVS is the prospect for conversion to larger access 8 
owing to complications during surgery. However, mini-MVS has been found to 9 
reduce the need for re-exploration for bleeding compared to conventional sternotomy. 10 
Chitwood Jr and colleagues(3) conducted a meta-analysis with 1553 participants 11 
showing reduced need for reoperation for bleeding with mini-MVS. Studies as early 12 
as 20 years ago also supported this notion reporting 1.8 units fewer red blood cell 13 
transfusion in patients undergoing mini-MVS compared to conventional 14 
sternotomy(4,5).  15 
3.2 Wound sepsis 16 
A smaller area of disruption in skin integrity allows for less inoculation with 17 
commensal microbes, especially in patients with diabetes, immunosuppression and 18 
higher body mass index. In an observational study conducted by Grossi et al. (5), the 19 
rates of septic wound complication in adult were 5.7% and 0.9% (p=0.05) in median 20 
sternotomy and mini-MVS groups, respectively. This benefit also continued to be 21 
evident in elderly patients(6).  22 
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3.3 Patient satisfaction (shorten) 1 
Mini-MVS is associated with less postoperative pain and quicker return to normal 2 
activity. This translates to an improved quality of life in the early post-operative 3 
period(7). Glower et al.(8) showed that patients found that pain resolved more 4 
quickly and were able to return to activities of daily living up to 5 weeks earlier after 5 
mini-MVS compared to median sternotomy, perhaps a result of improved 6 
stabilisation of the thorax (3,4). Furthermore, several studies have reported a 7 
demonstrable cost saving with mini-MVS which could be a result of shorter length of 8 
stay (LOS)(9–11). 9 
3.4 Benefits in redo surgery 10 
Redo cardiac surgery is traditionally performed through a repeat median sternotomy. 11 
However, this procedure is technically challenging due to dense adhesions and has 12 
a considerable risk of injuries to cardiac and vascular structures, which are 13 
independent risk factors for mortality(12). In 2018, a meta-analysis with a total of 777 14 
patients demonstrated mini-MVS as a valid alternative in redo MVS with significantly 15 
reduced rates in mortality, LOS and reoperation for bleeding(13). 16 
4 Training and learning curve   17 
Cautious management of the learning curve in surgical procedures can be a 18 
predictor of success(14)(15). Notably, the effect of learning curve on patient 19 
outcomes does not rely on individual surgeon’s experience but the entire operative 20 
team (16). 21 
Monitoring the institution’s progress through the learning curve is important. 22 
Cumulative sum (CUSUM) is a method to analyse a learning curve for a surgical 23 
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team, variability within surgeons and to predict the number of cases required in order 1 
to overcome the learning curve(17). A study using CUSUM analysis in 3895 mini-2 
MVS cases identified that adverse events (e.g. conversion to sternotomy, re-3 
exploration, stroke) reduced to the normal range of 10% after 250 cases(18). In 4 
addition, greater than 50 cases per annum are required to maintain most the 5 
favourable results, amounting to an optimal procedure rate of one per week.  6 
Yaffee et al(19) demonstrated significantly shorter learning curves for totally 7 
endoscopic robotic mitral valve repair as a result of focused training in both technical 8 
and non-technical skills. Comparatively, appropriate training in minimally invasive 9 
aortic valve replacement (mini-AVR) has also been possible without compromising 10 
patient safety(20), although the use of sutureless technology can aid with its learning 11 
curve(21) (an option not available for mini-MVS). 12 
Devising a specific training programme or fellowship in a large volume centre will 13 
allow surgical proficiency to be reached in a timely fashion, thus facilitating the 14 
uptake of mini-MVS into the healthcare system more readily. Mentorship can be 15 
organised through the provision of dedicated fellowships and mentor schemes, 16 
which can be uniquely facilitated via specialist societies, such as British and Irish 17 
Society of Minimally Invasive Cardiac Surgery (BISMICS) and Society of 18 
Cardiothoracic Surgeons of Great Britain & Ireland (SCTS). This can allow for 19 
targeted training of cardiac surgeons to promote the development of minimally 20 
invasive cardiac surgeons. Industry partners may play an important role in 21 
supporting proctors and surgeons. 22 
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5 Technical challenges to overcome  1 
Mini-MVS is a technically demanding complex procedure. Considerations for new 2 
learning curves have been proposed in mini-MVS, namely altered incisions, reduced 3 
operative space, endoscopic instrumentation, and aortic occlusion(22). The 4 
recommendations from this consensus statement are summarised in Table 1. 5 
5.1 Mitral valve repair 6 
Surgeons should be comfortable with the techniques of repair by operating on an 7 
adequate number of sternotomy access mitral procedures. The build up to mini-MVS 8 
should also be graduated, ensuring that the twenty initial cases are straightforward, 9 
commonly P2 prolapse cases, which could be considered the simplest mitral 10 
procedure.  11 
5.2 Incision size 12 
The goal of a thoracotomy incision is to make it less than 5cm in length which has 13 
numerous patient benefits. For the initial cases, the skin incision can be made 14 
slightly longer to assist visualisation as it is the avoidance of sternotomy or no rib-15 
spreading which provides clinical benefit. Beyond this, the relationship between 16 
volume and outcome remains true in mini-MVS, and it would not be unreasonable 17 
that the time to be considered an expert in mini-MVS may take a few years. 18 
Overcoming the challenges of operating in a reduced space is perhaps the largest 19 
challenge for the surgeon. 20 
5.3 Aortic occlusion 21 
Aortic occlusion is achieved currently by 2 techniques available to surgeons: i) 22 
transthoracic clamp (TTC); and ii) endoaortic balloon occlusion (EABO). The TTC 23 
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technique is simpler and involves inserting a clamp through the intercostal spaces to 1 
clamp the ascending aorta. The EABO technique is associated with a longer learning 2 
curve as the procedure requires more monitoring and experience. It involves 3 
accessing the aorta through a catheter inserted either in the femoral artery or directly 4 
through the ascending aorta with an inflatable balloon at its tip. This is guided by 5 
TOE, the balloon is inflated and the aorta occluded. In a recent meta-analysis, the 6 
only advantage of TTC over EAOB was the reduction in aortic dissection 7 
complications [risk ratio 0.33, 95% confidence interval (CI) 0.12-0.93; P = 0.04](23).  8 
The use of aortic occlusion method currently remains entirely down to surgical 9 
preference and newer adjuncts for aortic occlusion are yet to penetrate surgical 10 
practice. Importantly, occluding the aorta through AXT or EABO is a learning curve 11 
that the surgeons can only ascend during minimally invasive procedures. A useful 12 
option for TOE-guided cannulation, would be gaining the patient’s consent to 13 
practise percutaneous femoral cannulation on sternotomy or hemi-sternotomy cases 14 
could be a viable method for improving the surgeon’s familiarity with this alternative 15 
strategy. 16 
5.4 Endoscopic mini-MVS 17 
Thoracoscopes have been implemented in mini mitral surgery for over two decades 18 
helping to reduce complications via improved visualisation(24), although familiarity 19 
for their use is required and mainly specialised centres advocate performing mini-20 
MVS totally endoscopically(25). In 2008, Chitwood and colleagues described levels 21 
of minimally invasive mitral surgery based on the size of the incisions and 22 
progressive use of video assisted or robotic assisted surgery(26) (Table 2).  23 
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Robotic assisted mini-MVS techniques, although safe and effective, are associated 1 
with more difficult learning curves. Robotic surgery provides ergonomic gains which 2 
improve the surgical process and the smaller incision sizes are favoured by patients. 3 
Current evidence is mostly based on observational studies, and therefore 4 
randomised trials may be required in order to definitively assess the advantages and 5 
disadvantages of these techniques(27).  6 
6 Implementing the first few cases 7 
6.1 Early engagement with hospital and patients 8 
In most hospitals, all new procedures need prior approval from a hospital committee, 9 
which has ethical, cost, patient outcome and management considerations. This 10 
ensures patient safety, highlights clinical governance and maintains quality control. 11 
The hospital committee may have a specific application process and ask for 12 
prerequisite information prior to issuing favourable support. Usually, this involves 13 
description and indications of the proposed procedure, intended benefits, possible 14 
complications, summary of evidence base, estimated number of annual procedures 15 
to be performed and names of supporting colleagues(28).  16 
Evidence suggests that patients prefer detailed explanations of their treatment and 17 
decisions made surrounding it(29,30). Written material explaining why the 18 
department is employing the new procedure, evidence surrounding its use, as well 19 
as what patients should expect following the procedure should be offered containing 20 
visual aids and diagrams. Risks of mini-MVS should be explained openly and helps 21 
avoid confusion or anxiety.  22 
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6.2 Selecting the initial cases 1 
In the initial period (first 20 cases), appropriate patient selection is key. This ensures 2 
patient safety and allows the surgeon and team to “break in” to the novel procedure 3 
with as minimal complications as possible. In the early stages, should avoid: 4 
1. very elderly,  5 
2. grossly obese,  6 
3. current smokers  7 
4. high-risk (high Euroscore).  8 
5. complex repairs (stick to straightforward annuloplasty +/- P2 resection) 9 
In actual fact, it is these very patients who may benefit from mini-MVS the 10 
most(31,32). However, in the initial stages of implementation, the complication rate 11 
may be higher.  12 
Other contraindications to mini-MVS that would persist beyond the initial cases 13 
should also be described and made clear in the institution’s protocol. Although not 14 
absolute contraindications, each patient should be considered on an individual basis 15 
via a risk-benefit analysis and through the consideration of the multi-disciplinary 16 
process. The contraindications to be considered have been outlined in Table 3.   17 
6.3 Equipment needs 18 
An important recommendation for familiarisation with mini-MVS technology is to 19 
make use of them during established open procedures. This includes the 20 
thoracoscope, knot pusher and TOE-guided cannulation (Table 4). Space will be less 21 
restricted and safety for their use in these scenarios would not be compromised. 22 
Local departmental teaching attended by all involved personnel and team members 23 
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from different specialties should also be delivered. This allows for the following 1 
opportunities: 2 
1. Invited speakers from specialised centres or equipment companies 3 
2. Watching operative videos of the procedure 4 
3. Exploring the rationale of the new technology 5 
4. Group discussion 6 
5. Handling of specialised instruments and discussion surrounding their use 7 
6. Agree to one case per day for the whole team to allow adequate time for a full 8 
de-brief where each member of the team has a voice  9 
6.4 Trainees and surgical assistants 10 
Establishing the new service should have a long-term vision that includes 11 
transferring the knowledge and skills to junior colleagues who can lead and 12 
participate in the service in subsequent years. Including trainees in visits to 13 
specialised centres, teaching sessions and group discussions surrounding the new 14 
procedure should be encouraged. Assisting in the initial cases is also recommended. 15 
The use of high fidelity virtual reality simulation training has demonstrated benefit in 16 
many fields of minimally invasive surgery(33–35) including thoracoscopic surgery. 17 
This helps shorten the learning curve outside the operating theatre and hence 18 
improve patient safety whilst new procedures are being implemented.  19 
6.5 Staff considerations 20 
The importance of team concordance and communication surrounding these new 21 
process entities are paramount. In this light, the need for simulation is highly 22 
recommended. Scheduling a visit to a customised simulation centre with specialised 23 
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assessment equipment and simulated theatres is extremely useful. Specialised 1 
audio-visual equipment can allow for unique playback and feedback opportunities to 2 
allow team members to improve on personal aspects of communication. Promoting 3 
positive relations and trust between the team members play an important role in 4 
ensuring the efficient running of complex procedures. Studies in many surgical 5 
specialties have shown that the familiarity of team members is key to minimising 6 
operative related complications, reduce operative time and improve patient 7 
outcomes(36,37).  8 
Devising 1-2 mini mitral specific checklists is also highly recommended. This will help 9 
reduce untoward error related to equipment, staff, or theatre processes. This may be 10 
used to benefit specific staff, or groups of staff, members, for example scrub nurses 11 
when checking equipment preparation and theatre ODPs when checking theatre and 12 
patient readiness.  13 
It is important to note that initiating a novel mini-MVS service has significant benefits 14 
for the institution. For the staff, this can be a catalyst for improving team morale, self-15 
belief and skill progression. Becoming a unit that collectively leads in the 16 
implementation of new technology and techniques will carry both staff and patient 17 
benefit. 18 
7 Dealing with adverse events 19 
Establishing a culture of objectivity is critical for the audit process. This involves the 20 
leading members of the service and team promoting an ethos of openness, honesty 21 
and devoid of blame. Moving to a Mini-MVS approach does expose the surgeon and 22 
his team to a different set of complications related to alternative cannulation 23 
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strategies and new incisions. All adverse outcomes need to be clearly documented 1 
and each can be virtually eliminated by constant improvements in both technique 2 
and technology used. Regular conversations with a mentoring surgeon or team helps 3 
understand specific complications and leads to a lower incidence. 4 
7.1 Bleeding and re-exploration 5 
 6 
One of the underlying causes of conversion from mini-MVS to median sternotomy is 7 
bleeding(49), although literature has shown that mini-MVS leads to a reduction in 8 
bleeding and re-exploration compared to sternotomy(38). Management of post-9 
operative bleeding should adhere to strict standards as with other cardiac surgical 10 
procedures. The need for adequate surgical re-exploration for severe haemorrhage 11 
should not be overshadowed by the desire to maintain the integrity of minimal 12 
access(38). In the first instance, hypothermia and acidosis should be closely 13 
monitored, and crystalloid administration should be minimised to avoid 14 
haemodilution(39). Additionally, excessive hypertension should be avoided, and 15 
mean arterial pressure levels should not be allowed to run higher than 90mmHg(40) 16 
and timely transfusion with blood products is required(41).  17 
Dense pulmonary adhesions are another cause of conversion to sternotomy. This is 18 
associated with patients with a background of pulmonary diseases(42). Hence, a 19 
detailed pre-operative computerised tomography (CT) scan with anatomical 20 
consideration and detailed MDT discussion should be carried out in these patients. 21 
 22 
7.2 Pulmonary oedema 23 
There have been reports of unilateral pulmonary oedema (a rare but life-threatening 24 
complication) occurring after mini-MVS(43), with the pathophysiology thought to be 25 
inflammatory related. The cause-effect relationship is yet to be established, as many 26 
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cases of severe pulmonary oedema can also be observed following sternotomy 1 
access for cardiac procedures. Two landmark trials found a role for peri-operative 2 
intravenous steroids in sternotomy cardiac patients for the significant reduction in the 3 
incidence of pulmonary oedema(44,45) although this has not been formerly trialled in 4 
mini-MVS. Retrospective studies in mini-MVS have found that the introduction of 5 
peri-operative steroids in mini-MVS may lead to a reduced incidence of clinical and 6 
radiological pulmonary oedema(46). Careful ventilatory strategies may also need to 7 
be employed to reduced volu- and barotrauma related lung injury(47).  8 
7.3 Phrenic nerve palsy 9 
 10 
The risk of phrenic nerve palsy with mini-MVS has been reported to increase by 3% 11 
compared to conventional sternotomy(38). This can have adverse implications as 12 
patients may experience respiratory distress and prolonged ventilation(48). It is 13 
speculated phrenic nerve palsy results from excessive pull on pericardial traction 14 
sutures which are used for better visualisation of the left atrium(48). Therefore, 15 
measures to incise the pericardium further away from the phrenic nerve (preferably 16 
>3 cm) and avoid retraction sutures near the nerve to prevent extensive pull(3) are 17 
advocated. It is important to note that phrenic injury is an avoidable complication, 18 
which gives emphasis to the importance of rigorous attention to this part of the 19 
procedure when training surgeons in mini-MVS. 20 
 21 
7.4 Pain 22 
 23 
Although Mini-MVS confers a smaller incision, chronic pain can develop as a result 24 
of intercostal nerve damage(49). Randomised control studies are lacking in this area, 25 
although the use of various analgesic techniques have been reported. The use of a 26 
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catheter inserted in close proximity to intercostal space before skin closure with 1 
administration of 75 mg of 0.75% ropivacaine has been shown to eliminate early 2 
post-operative pain(49). Alternatively, intercostal nerve blockade combined with 3 
general anaesthesia has also been reported(50) achieved by the administration of 4 
0.5% ropivacaine from T3 to T7 prior to anaesthesia induction. Intractable cases of 5 
chronic pain secondary to intercostal nerve traction is likely to require input from 6 
neuropathic pain specialists to employ patient specific therapy. Most cases of pain 7 
tend to resolve within 12 months, and many lessons can be drawn from thoracic 8 
surgical practice whose patients frequently have pain related to the intercostal nerve. 9 
8 Conclusion 10 
This consensus statement has outlined the important considerations and processes 11 
for establishing a workable, effective and sustainable mini-MVS service in a modern 12 
UK healthcare system. The aim of the authors is to promote standardised practice to 13 
allow the effective and safe dissemination of novel technology in healthcare for the 14 
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Table 1: Summary of recommendations for mini-MVS 1 
Patient selection  
1. Patients with degenerative MR may be considered for minimally invasive mitral surgery 
with comparable outcomes to full sternotomy. 
2. Patients who have had previous cardiac surgery and require intervention on the mitral 
valve can be considered for minimally invasive mitral surgery. 
3. In the initial stages of implementing a mini-mitral service, low risk patients should be 
selected who also have a lower chance of complications (non-smokers, low BMI, non-
diabetic, P2 prolapse). 
 
Cardio-pulmonary Bypass 
4. The use of either an endo-aortic balloon or external cross clamp are recommended 
during minimal access mitral surgery, with little evidence of one preference over the 
other. 
5. Femoral or direct aortic cannulation are both acceptable strategies to institute cardio-
pulmonary bypass. 
6. The use of TOE guidance for arterial and venous cannula positioning during the 
institution of cardiopulmonary bypass is highly recommended. 
 
Staff/Governance 
7. The use of simulation with the surgical team prior to conducting the first live case of 
minimal access mitral surgery is highly recommended. 
8. The implementation of a “dry run” in the unit’s theatre using the relevant equipment and 
staff is recommended. 
9. Regular audit of initial mini mitral cases at a surgical unit, and subsequent mini mitral 
cases is highly recommended 
 2 
 3 
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Table 2: Levels of minimally invasive cardiac surgery. Adapted from Chitwood et al 1 
1997 (9) 2 
Level 1 Direct vision: (10–15 cm incisions) 
Level 2 Direct vision/video assisted with mini incisions (4–6 cm) 
Level 3 Video directed and robot assisted with micro incisions (1.5–4 cm) 
Level 4 
Robotic (computer telemanipulation) and totally endoscopic port incisions 


























Contraindication Implications for mini mitral surgery Methods to circumvent  
Prior right chest surgery or 
radiation 
Patients are at increased risk due to 
pleural adhesions 
Preoperative CT scan can 
allow for operative planning 
with specific adjuncts and 
techniques to avoid damage 
to major structure (50,51) 
Severe peripheral 
atherosclerosis or chronic 
peripheral arterial occlusive 
disease. Descending aorta 
aneurysm, aortic dissection, 
aortic thrombus 
Peripheral cannulation for CPB can 
be particularly challenging for these 
patients 
Alternate routes of CPB to be 
considered or full sternotomy 
Prominent ascending 
aorta calcifications or 
ascending aorta 
aneurysm/dilation (> 4.5 cm) 
Aortic clamping and 
antegrade cardioplegia administration 
are challenging in these patients. 
Consider endo-balloon or 
percutaneous mitral valve 
repair 
Moderate to severe aortic 
regurgitation (AR) 
Difficulties with cardioplegia 
administration 
Conventional sternotomy 
Significant chest wall 
deformity (particularly severe 
pectus excavatum) 
Challenging access to all intra-
thoracic structures 
Conventional sternotomy 
Severe mitral annular 
calcification. 
Extensive decalcification of the mitral 
annulus and reconstruction with a 
pericardial patch is very challenging 
through a minimal invasive approach 
Conventional sternotomy or 
Percutaneous mitral valve 
replacement 






Table 4 Technical aspects of minimal access mitral surgery and relevant ways to 4 





























 √  √ √ 
TOE guided aortic 
cannulation 
 
√  √ √ √ 
Aortic occlusion 
 
   √ √ 
Knot pushing 
 √ √ √ √ √ 
 
Thoracoscopic  adjunct √   √ √ 
